1AI 14.3% 0.8¢ algorae pharmaceuticals limited

Ann: Positive results from AI-116 in vitro studies, page-18

  1. 4,646 Posts.
    lightbulb Created with Sketch. 696
    FY General Info....interesting space

    Advances in generative AI have taken the tech world by storm. Biotech investors are making a big bet that similar computational methods could revolutionize drug discovery.

    On Tuesday, ARCH Venture Partners and Foresite Labs, an affiliate of Foresite Capital, announced that they incubated Xaira Therapeutics and funded the AI biotech with $1 billion. Other investors in the new company, which has been operating in stealth mode for about six months, include F-Prime, NEA, Sequoia Capital, Lux Capital, Lightspeed Venture Partners, Menlo Ventures, Two Sigma Ventures and SV Angel.

    https://techcrunch.com/2024/04/24/x...-1b-says-its-ready-to-start-developing-drugs/

    https://www.biospace.com/article/ai...x-genentech-execs-look-to-transform-r-and-d-/
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.001(14.3%)
Mkt cap ! $13.49M
Open High Low Value Volume
0.8¢ 0.8¢ 0.7¢ $3.254K 428.7K

Buyers (Bids)

No. Vol. Price($)
15 7039574 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 247546 1
View Market Depth
Last trade - 13.35pm 19/08/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.